DUBLIN--(BUSINESS WIRE)--The "Induced Pluripotent Stem Cells Market" report has been added to ResearchAndMarkets.com's offering.
The Induced Pluripotent Stem Cells Market was valued at USD 3.4 billion in 2023, and is projected to reach USD 5.2 billion by 2028, rising at a CAGR of 9.10%.
The rapid evolution of human iPSC technology since 2007 led to an exciting new age for the fields of disease modeling, drug discovery, stem cell biology and regenerative medicine. However, there are certain challenges associated with the use of iPSCs, including issues with clonal selection, in vitro culture, adaptability, and/or cell multiplication. Thus, even though the field of iPSCs has come a long way, there are still many issues that need to be seriously addressed to transform hope to reality regarding the effective clinical application of these cells in regenerative medicine.
Report Scope
This report summarizes the single-use technologies market, including a market snapshot and company profiles of key players. It provides a comprehensive market breakdown with in-depth information regarding each segment. The overview section of the report describes market trends and dynamics, including drivers, challenges and opportunities for the market. It provides information on emerging technologies and developments in the industry. It analyzes critical market players' financials, product portfolios and recent activities.
The report analyzes and makes projections for each market and its applications, along with forecasts for the next five years. The report also features profiles of leading companies in the biopharmaceutical single-use technologies industry, including Sartorius AG, Danaher Corp, Merck KGaA and Thermo Fisher Scientific Inc.
Data for market estimates have been provided for 2021 and 2022 as the historical years, 2023 as the base year and forecast through 2029.
The report includes:
- 220 data tables and 59 additional tables
- An analysis of the global markets for single-use technologies for biopharmaceutical manufacturing
- Analyses of global market trends, with market revenue data from 2021 to 2023, estimates for 2024, and projected CAGRs through 2029
- Estimates of the size and revenue prospects of the global market, along with a market share analysis by technology, single-use component, application, end user, and region/country
- A look at recent technical advances in different sole-use technologies and bioreactors and the extent of adoption by commercial customers and regulatory authorities
- Facts and figures pertaining to the market dynamics, technical advances, regulations, and the impact of region- and industry-specific macroeconomic variables
- A Porter's Five Forces model, and global supply chain and PESTLE analyses
- Patent activity and key patent grants/publications, along with an analysis of the impact of new developments in sole-use technologies and bioreactors for pharmaceuticals
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, ESG score analysis, and the ESG practices of leading companies
- Analysis of the industry structure, including company market shares, strategic alliances, M&A activity and a venture funding outlook
- Profiles of market leaders, including: Danaher Corp, Thermo Fisher Scientific Inc., Sartorius AG and Merck KGaA.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 152 |
| Forecast Period | 2023 - 2028 |
| Estimated Market Value (USD) in 2023 | $3.4 Billion |
| Forecasted Market Value (USD) by 2028 | $5.2 Billion |
| Compound Annual Growth Rate | 9.1% |
| Regions Covered | Global |
Key Topics Covered:
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Induced Pluripotent Stem Cells (iPSC) Generation
Chapter 3 Market Dynamics
-
Market Drivers
- Increasing Prevalence of Chronic Diseases
- Increasing Investment in Biotechnology Industry
- Increasing Demand for Personalized Medicines
- Increasing Investments for Drug Research and Development
- Demand for Effective Drug Discovery and Development Process
- Minimizing Animal Testing
-
Market Restraints
- High Development Costs and Lack of Skilled Workforce
- Challenges Associated with iPSC-based Disease Modeling, Cell Therapy and Drug Discovery
-
Market Opportunities
- Technological Advances
- Growth in iPSC Banking
Chapter 4 Emerging Technologies and Developments
- Advances in the iPSC Research
- Reprogramming Technologies
- Gene Editing Technologies
- 3D Organoids
- Regenerative Medicine
- Evolution and Current Application of Artificial Intelligence (AI) in iPSC Research
Chapter 5 Clinical Trial Analysis
Chapter 6 Patent Analysis
Chapter 7 Market Segmentation Analysis
- Generation of Induced Pluripotent Stem Cells -- Market Analysis, by Reprogramming Method
- Market for Induced Pluripotent Stem Cells, by Generation Method
-
Market for Induced Pluripotent Stem Cells, by Application
- Academic Research
- Pharmaco-toxicological Screening
- Drug Discovery and Development
- Disease Modeling
- Tissue Engineering
- Cell Therapy
- Global Market
- Regional Markets for iPSCs, by Application
-
iPSC-derived Tissue Cell Market, by Type
- Cardiomyocytes
- Neurons
- Endothelial Cells
- Hepatocytes
- Other Cells
- iPSC-derived Tissue Cell Market, by Species
- iPSC-derived Tissue Cell Market, by Application
- Market for Induced Pluripotent Stem Cells, by Product Function
- Regional Markets for iPSCs, by Product Function
- Market for Induced Pluripotent Stem Cells, by End Use
- Induced Pluripotent Stem Cell Contract Service Types
- Major Players
- Global Market
- Geographic Breakdown
Chapter 8 Competitive Intelligence
- Competitive Landscape -- Overview
- Strategic Analysis
- Agreements
- Collaborations & Strategic Alliances
- Partnerships
- New Product Development and Launches
- Expansions and Acquisitions
- Fund Raising
- Approval and Clinical Trials
- Others
- Major Companies in Induced Pluripotent Stem Cells Market, by Type of Offerings
Company Profiles
- ATCC
- Axol Bioscience
- Bio-Techne
- Fujifilm Cellular Dynamics
- Lonza
- Merck
- Ncardia
- Qiagen
- Reprocell Inc.
- Stemcell Technologies
- Takara Bio Inc.
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/r/e5l2jx
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
